Spermidine regulates RIPK1 to combat diabetes and vascular damage

Researchers reveal that spermidine-mediated acetylhypusination of RIPK1 suppresses necroptosis and insulin resistance, offering potential therapeutic strategies for type 2 diabetes.

Qiagen, AstraZeneca expand companion diagnostic pact beyond cancer

Dive Brief: Qiagen said Wednesday it has expanded its collaboration with AstraZeneca to cover companion diagnostics for chronic diseases. The agreement, which moves the partnership

August 29, 2024

Nonsteroidal Topical OK’d for Atopic Dermatitis

The FDA approved tapinarof cream 1% (Vtama) for eczema in individuals ages 2 years and older, drugmaker Organon announced on Monday. Approval of the topical

December 18, 2024

Single Monoclonal Antibody Injection Protected Kids Against Malaria

A single subcutaneous injection of an investigational monoclonal antibody was safe and effective in preventing malaria in children in Mali, according to results of the

April 27, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.